Implement Strategies to Tackle the IVIG Shortage
September 2019
Dwindling supplies will lead to questions about how to handle the intravenous immune globulin (IVIG) shortage.
The shortage seems to be due to demand that is outpacing plasma donations...plus long manufacturing times.
Expect your hospital to reserve IVIG for severe acute cases, such as Guillain-Barre, Kawasaki disease, or myasthenia gravis crisis. You may also see IVIG alternatives when possible...such as plasmapheresis.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote